Stimcell Energetics (STME) Non-Current Debt (2018 - 2023)
Stimcell Energetics' (STME) quarterly Non-Current Debt came in at $52747.0 in Q4 2023, down 53.01% year-on-year from $112245.0 in Q4 2022, and down 68.75% quarter-over-quarter from $168804.0 in Q3 2023.
Stimcell Energetics (STME) Non-Current Debt (2018 - 2023) Analysis & Trends
Stimcell Energetics' Non-Current Debt history runs 6 years deep, the most recent figure standing at $52747.0 for Q4 2023.
- On a quarterly basis, Non-Current Debt fell 53.01% year-over-year to $52747.0 in Q4 2023; TTM through Nov 2023 was $52747.0, a 53.01% decrease from a year earlier, with the FY2023 full-year figure at $165609.0, up 49.35% from the prior year.
- Non-Current Debt slipped to $52747.0 in Q4 2023 per STME's latest filing, from $168804.0 in the prior quarter.
- Across five years, Non-Current Debt topped out at $757305.0 in Q1 2021 and bottomed at $52747.0 in Q4 2023.
- The 5-year median for Non-Current Debt is $363826.0 (2019), against an average of $333767.6.
- Across the five-year window, Non-Current Debt jumped 335.69% in 2019 and slumped 78.94% in 2021, its largest moves.
- Year by year, Non-Current Debt stood at $363826.0 in 2019, then surged by 77.6% to $646173.0 in 2020, then declined by 26.88% to $472481.0 in 2021, then plunged by 76.24% to $112245.0 in 2022, then slumped by 53.01% to $52747.0 in 2023.
- Per Business Quant, the three latest STME Non-Current Debt figures stand at $52747.0 (Q4 2023), $168804.0 (Q3 2023), and $165609.0 (Q2 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.18 Bn |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2023 | 52,747.00 |
| Aug 31, 2023 | 168,804.00 |
| May 31, 2023 | 165,609.00 |
| Feb 28, 2023 | 143,978.00 |
| Nov 30, 2022 | 112,245.00 |
| Aug 31, 2022 | 111,469.00 |
| May 31, 2022 | 110,888.00 |
| Feb 28, 2022 | 561,167.00 |
| Nov 30, 2021 | 472,481.00 |
| Aug 31, 2021 | 377,702.00 |
| May 31, 2021 | 105,831.00 |
| Feb 28, 2021 | 757,305.00 |
| Nov 30, 2020 | 646,173.00 |
| Aug 31, 2020 | 591,895.00 |
| May 31, 2020 | 502,437.00 |
| Feb 29, 2020 | 422,899.00 |
| Nov 30, 2019 | 363,826.00 |
| Aug 31, 2019 | 162,374.00 |
| May 31, 2019 | 511,754.00 |
| May 31, 2018 | 117,459.00 |